NEC Ties Up with French Biotech to Develop Neoantigen Vaccines Using AI

May 28, 2019
Dr Quéméneur (left) and Mr Fujikawa Japanese electronics maker NEC has linked arms with French biotech Transgene to develop individualized neoantigen vaccines for cancer patients by leveraging its own AI technologies, making a full foray into the drug discovery business,...read more